Stock Report

All about this stock under one free report Last Updated: 02-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

PLUS THERAPEUTICS (PSTV) Key Ratios

Stock Card factsheet share-fund-plan-icon

$3.84

up-down-arrow $0.07 (1.80%)

As on 07-Aug-2026 09:30EDT

Market cap

info icon

$27 Mln

Revenue (TTM)

info icon

$4 Mln

P/E Ratio

info icon

0.2

P/B Ratio

info icon

4.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -60.02 -70.43 -20.95 17.60 391.26
EBIT -29.14 -273.71 -49.73 -14.17 -178.72
Net Profit -29.66 -274.84 -37.11 -21.70 -183.58
EPS -27.22 -5,499.03 -91.77 14.93 11.53
Book Value -- -- -- -29.61 13.40
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -260.70-2,379.00-539.71-360.20-158.89
Net Margin info -----620.70----
Return on equity info 211.1741.12-551.60903.94252.07
Return on Capital info 2,206.531,277.67--5,852.55944.20
Return on Assets info -138.20-116.33-120.04-195.02-144.03
Debt to Equity (x) info ----0.000.21-0.38

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
5,852.55
944.20
-177.16
-135.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-551.60

Lower than Peers by 511.20

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-551.60
903.94
252.07
-522.50
-234.65
Peer Median
-40.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-120.04

Lower than Peers by 89.06

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-120.04
-195.02
-144.03
-75.54
-88.44
Peer Median
-30.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-539.71

Lower than Peers by 456.09

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-539.71
-360.20
-158.89
-263.00
-8,733.93
Peer Median
-83.62
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-620.70

Lower than Peers by 528.03

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-620.70
-429.43
-222.84
-271.04
-9,051.34
Peer Median
-92.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-20.95

Lower than Peers by 74.90

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-20.95
-0.10
0.19
20.93
--
Peer Median
53.95
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-49.73

Lower than Peers by 48.93

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-49.73
-102.91
28.38
33.96
-56.93
Peer Median
-0.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-37.11

Lower than Peers by 29.81

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-37.11
-72.49
2.54
34.32
-51.32
Peer Median
-7.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-91.77

Lower than Peers by 106.42

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-91.77
-2.27
0.26
0.74
0.30
Peer Median
14.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

5,460.27

Higher than Peers by 5,470.45

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
5,460.27
--
--
--
--
Peer Median
-10.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
0.21
-0.38
-3.10
0.89
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
0.01
0.20
-0.37
-3.04
0.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.37

Lower than Peers by 4.44

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
1.37
1.23
0.34
0.92
1.84
Peer Median
5.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.37

Lower than Peers by 4.32

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
1.37
--
--
--
--
Peer Median
5.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-7.46

Lower than Peers by 5.37

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
-7.46
-5.20
-2.48
-32.71
-27.52
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

41.90

Higher than Peers by 22.76

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
41.90
--
9.80
--
--
Peer Median
19.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.19

Higher than Peers by 0.13

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
0.19
0.45
0.65
0.28
0.01
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
40.01
35.81
--
11.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
--
--
--
-3.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
5,232.51
3,050.61
247.31
2,815.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
--
--
--
-2,807.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

0.18

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
0.18
-0.07
-0.52
-0.59
-0.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.31

Lower than Peers by 0.87

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
4.31
0.40
-0.76
-5.84
0.09
Peer Median
5.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

29.14

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
29.14
0.58
-0.78
-0.28
0.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

27

Lower than Peers by 119

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
PLUS THERAPEUTICS (PSTV)
27
--
--
--
--
Peer Median
146
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...